InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| pSELECT-puro | Phosphorylation of ORF1p is required for L1 retrotransposition. | 2015 | PNAS | Cook P.R. et al. | DOI: 10.1073/pnas.1416869112 |
| FLA-ST (Standard or Ultrapure) | Leukocyte TLR5 deficiency inhibits atherosclerosis by reduced macrophage recr... | 2017 | Sci Rep. | Ellenbroek G.H. et al. | DOI: 10.1038/srep42688 |
| Pepinh-MYD | MV140, a sublingual polyvalent bacterial preparation to treat recurrent urina... | 2016 | Mucosal Immunol. | Benito-Villalvilla C. et al. | DOI: 10.1038/mi.2016.112 |
| Anti-hTLR6 Neutralizing mAb | TLR2 Plays a Key Role in Platelet Hyperreactivity and Accelerated Thrombosis ... | 2017 | Circ Res. | Biswas S. et al. | DOI: 10.1161/CIRCRESAHA.117.311069 |
| IFN-α/β Reporter HEK 293 Cells | Src family kinases Fyn and Lyn are constitutively activated and mediate plasm... | 2017 | Nat Commun. | Dallari S. et al. | DOI: 10.1038/ncomms14830 |
| LPS-PG (Lipopolysaccharide from P. gingivalis) | Lipopolysaccharide and IL-1β coordinate a synergy on cytokine production by u... | 2016 | Mol Immunol. | Brinson C.W. et al. | DOI: 10.1016/j.molimm.2016.09.020 |
| CPPD Crystals | The PYRIN domain-only protein POP2 inhibits inflammasome priming and activation. | 2017 | Nat Commun. | Ratsimandresy R.A. et al. | DOI: 10.1038/ncomms15556 |
| ODN 1668 - TLR9 ligand | Protective effects of Fc-fused PD-L1 on two different animal models of colitis. | 2015 | Gut | Song M.Y. et al. | DOI: 10.1136/gutjnl-2014-307311 |
| PlasmoTest™ - Mycoplasma Detection Kit | GlycoDelete engineering of mammalian cells simplifies N-glycosylation of reco... | 2014 | Nat Biotechnol. | Meuris L. et al. | DOI: 10.1038/nbt.2885 |
| Recombinant anti-CD20 antibody (Rituximab biosimilar - IgG1NQ isotype) | Surrogate CD16-expressing effector cell lines for determining the bioactivity... | 2017 | J Pharm Biomed Anal. | Gurjar S.A. et al. | DOI: 10.1016/j.jpba.2017.06.004 |
| Poly(I:C) HMW | The COP II adaptor protein TMED7 is required to initiate and mediate the deli... | 2014 | Sci Signal. | Liaunardy-Jopeace A. et al. | DOI: 10.1126/scisignal.2005275 |
| RAW-Blue™ Cells | Macrophage Reporter Cell Assay for Screening Immunopharmacological Activity o... | 2014 | Antimicrob Agents Chemother. | Lewis R.E. et al. | DOI: 10.1128/AAC.02408-13 |
| Pam2CSK4 | Staphylococcus aureus PSM peptides induce tolerogenic dendritic cells upon tr... | 2016 | Int J Med Microbiol. | Armbruster N.S. et al. | DOI: 10.1016/j.ijmm.2016.09.002 |
| Poly(I:C) (HMW) / LyoVec™ | The DNA Sensor, Cyclic GMP-AMP Synthase, Is Essential for Induction of IFN-β ... | 2014 | J Immunol. | Zhang Y. et al. | DOI: 10.4049/jimmunol.1302718 |
| HEK-Blue™ mNOD1 | Activation of an innate immune receptor, Nod1, accelerates atherogenesis in A... | 2015 | J Immunol. | Kanno S. et al. | DOI: 10.4049/jimmunol.1302841 |
| QUANTI-Blue™ | Triggering Dectin-1-pathway alone is not sufficient to induce cytokine produc... | 2016 | PLoS One | Walachowski S. et al. | DOI: 10.1371/journal.pone.0148464 |
| 5'ppp-dsRNA | TRIM Protein-Mediated Regulation of Inflammatory and Innate Immune Signaling ... | 2013 | J Virol. | Uchil P.D. et al. | DOI: 10.1128/JVI.01804-12 |
| CARD11 | Germline hypomorphic CARD11 mutations in severe atopic disease. | 2017 | Nat Genet. | Ma CA. et al. | DOI: 10.1038/ng.3898 |
| ODN 2006 FITC | Primary blood neutrophils express a functional cell surface Toll-like recepto... | 2013 | Eur J Immunol. | Lindau D. et al. | 43(8):2101-13. |
| Plasmocure™ - Mycoplasma Elimination Reagent | MicroRNA-375 suppresses extracellular matrix degradation and invadopodial act... | 2015 | Arch Pathol Lab Med. | Jimenez L. et al. | DOI: 10.5858/arpa.2014-0471-OA |